Ganglioside GD2 anticorps (PE-Cy7)

N° du produit ABIN2667320

Cet anticorps anti-Ganglioside GD2 est un anticorps Souris Monoclonal détectant Ganglioside GD2 dans FACS. Adapté pour Humain.

Aperçu rapide pour Ganglioside GD2 anticorps (PE-Cy7) (ABIN2667320)

Antigène: Ganglioside GD2

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Ganglioside GD2 est conjugé à/à la PE-Cy7

Application: Flow Cytometry (FACS)

Clone: 14G2a

Détail du produit anti-Ganglioside GD2 anticorps (PE-Cy7)

Purification: The antibody was purified by affinity chromatography and conjugated with PE/Cy7 under optimal conditions. The solution is free of unconjugated PE/Cy7 and unconjugated antibody.

Isotype: IgG2a kappa

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Protect from prolonged exposure to light. Do not freeze.

Stock: 4 °C

Stockage commentaire: The antibody solution should be stored undiluted between 2°C and 8°C.

Détails sur Ganglioside GD2

Antigène: Ganglioside GD2

Sujet: Ganglioside GD2 is a sialic acid-containing glycosphingolipid involved in cell attachment to the extracellular matrix. Expression of GD2 in normal tissue is restricted to cells from the central nervous system, peripheral nerves, skin melanocytes, and mesenchymal stem cells. However GD2 is highly expressed by tumors of neuro-ectodermal origin such as melanomas, gliomas, neuroblastomas, and small cell lung carcinoma. GD2 has been proposed as a marker for some cancer stem cells.